2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| AI Biotechnology LLC | 10% Owner | 55,911,648 | Aug 17, 2022 |
| Access Industries Holdings LLC | 10% Owner | 55,911,648 | Aug 17, 2022 |
| Access Industries Management, Llc | 10% Owner | 55,911,648 | Aug 17, 2022 |
| Blavatnik Len | 10% Owner | 55,911,648 | Aug 17, 2022 |
| Sonsini Peter W. | — | 40,868,505 | Jan 4, 2021 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | Oct 8, 2025 | Fisher Andrew | General Counsel | Neutral | 47.5 | -1,349,887 | -100.00% | ✗ | - |
| Oct 7, 2025 | Oct 8, 2025 | ZACCARDELLI DAVID | CEO | Neutral | 47.5 | -15,461,424 | -100.00% | ✗ | - |
| Oct 7, 2025 | Oct 8, 2025 | Rickard Kathleen A. | Chief Medical Officer | Neutral | 47.5 | -3,564,852 | -100.00% | ✗ | - |
| Oct 7, 2025 | Oct 8, 2025 | Hahn Mark W | CFO | Neutral | 47.5 | -14,550,248 | -100.00% | ✗ | - |
| Oct 7, 2025 | Oct 8, 2025 | Austwick Michael | Director | Neutral | 47.5 | -84,712 | -100.00% | ✗ | - |
| Oct 7, 2025 | Oct 8, 2025 | Ullman Anders | Director | Neutral | 47.5 | -430,856 | -100.00% | ✗ | - |
| Oct 7, 2025 | Oct 8, 2025 | SHAH MAHENDRA | Director | Neutral | 47.5 | -165,472 | -100.00% | ✗ | - |
| Oct 7, 2025 | Oct 8, 2025 | Sinha Vikas | Director | Neutral | 47.5 | -166,112 | -100.00% | ✗ | - |
| Oct 7, 2025 | Oct 8, 2025 | Deschamps Lisa | Director | Neutral | 47.5 | -156,856 | -100.00% | ✗ | - |
| Oct 7, 2025 | Oct 8, 2025 | EBSWORTH DAVID R | Director | Neutral | 47.5 | -1,570,099 | -100.00% | ✗ | - |
| Oct 7, 2025 | Oct 8, 2025 | Edwards Martin | Director | Neutral | 47.5 | -229,992 | -100.00% | ✗ | - |
| Oct 7, 2025 | Oct 8, 2025 | Brady James Aloysius | Director | Neutral | 47.5 | -95,176 | -100.00% | ✗ | - |
| Oct 7, 2025 | Oct 8, 2025 | Cunningham Kenneth | Director | Neutral | 47.5 | -151,776 | -100.00% | ✗ | - |
| Oct 7, 2025 | Oct 8, 2025 | ACKERMANN CHRISTINA | Director | Neutral | 47.5 | -136,072 | -100.00% | ✗ | - |
| Aug 29, 2025 | Sep 3, 2025 | ZACCARDELLI DAVID | CEO | Neutral | 27.5 | -1,200,000 | -8.97% | ✗ | - |
| Aug 29, 2025 | Sep 3, 2025 | Rickard Kathleen A. | Chief Medical Officer | Neutral | 27.5 | -189,600 | -7.27% | ✗ | - |
| Aug 29, 2025 | Sep 3, 2025 | Hahn Mark W | CFO | Neutral | 27.5 | -1,200,000 | -9.63% | ✗ | - |
| Aug 1, 2025 | Aug 5, 2025 | Cunningham Kenneth | Director | Sell | 42.5 | -10,808 | -11.93% | ✗ | $142.1K |
| Aug 1, 2025 | Aug 5, 2025 | Deschamps Lisa | Director | Sell | 42.5 | -9,464 | -10.03% | ✗ | $124.4K |
| Aug 1, 2025 | Aug 5, 2025 | Fisher Andrew | General Counsel | Sell | 42.5 | -9,584 | -2.24% | ✗ | $126K |
| Aug 1, 2025 | Aug 5, 2025 | Hahn Mark W | CFO | Sell | 40.0 | -208,912 | -1.65% | ✓ | $2.7M |
| Aug 1, 2025 | Aug 5, 2025 | Rickard Kathleen A. | Chief Medical Officer | Sell | 38.8 | -58,336 | -2.19% | ✓ | $766.8K |
| Aug 1, 2025 | Aug 5, 2025 | ACKERMANN CHRISTINA | Director | Sell | 46.3 | -1,808 | -2.74% | ✗ | $23.8K |
| Aug 1, 2025 | Aug 5, 2025 | Austwick Michael | Director | Sell | 42.5 | -11,288 | -47.03% | ✗ | $148.4K |
| Aug 1, 2025 | Aug 5, 2025 | Brady James Aloysius | Director | Sell | 46.3 | -824 | -3.43% | ✗ | $10.8K |
| Aug 1, 2025 | Aug 5, 2025 | ZACCARDELLI DAVID | CEO | Sell | 40.0 | -208,912 | -1.54% | ✓ | $2.7M |
| Aug 1, 2025 | Aug 5, 2025 | EBSWORTH DAVID R | Director | Sell | 51.3 | -1,904 | -0.13% | ✗ | $25K |
| Aug 1, 2025 | Aug 5, 2025 | Edwards Martin | Director | Sell | 42.5 | -10,808 | -6.40% | ✗ | $142.1K |
| Aug 1, 2025 | Aug 5, 2025 | SHAH MAHENDRA | Director | Sell | 46.3 | -3,608 | -3.72% | ✗ | $47.4K |
| Aug 1, 2025 | Aug 5, 2025 | Sinha Vikas | Director | Sell | 42.5 | -4,328 | -4.40% | ✗ | $56.9K |
| Aug 1, 2025 | Aug 5, 2025 | Ullman Anders | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 7, 2025 | Jul 9, 2025 | Hahn Mark W | CFO | Sell | 40.0 | -90,320 | -0.72% | ✗ | $1M |
| Jul 7, 2025 | Jul 9, 2025 | Rickard Kathleen A. | Chief Medical Officer | Sell | 40.0 | -37,616 | -1.43% | ✗ | $430.4K |
| Jul 7, 2025 | Jul 9, 2025 | Fisher Andrew | General Counsel | Sell | 40.0 | -39,464 | -8.85% | ✗ | $451.5K |
| Jul 7, 2025 | Jul 9, 2025 | ZACCARDELLI DAVID | CEO | Sell | 40.0 | -90,320 | -0.67% | ✗ | $1M |
| Jun 16, 2025 | Jun 18, 2025 | Fisher Andrew | General Counsel | Sell | 17.5 | -80,000 | -18.18% | ✓ | $922K |
| May 15, 2025 | Jun 18, 2025 | Fisher Andrew | General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Hahn Mark W | CFO | Sell | 32.5 | -400,000 | -3.15% | ✓ | $4.6M |
| Jun 11, 2025 | Jun 13, 2025 | ZACCARDELLI DAVID | CEO | Sell | 36.3 | -400,000 | -2.94% | ✓ | $4.6M |
| May 27, 2025 | May 29, 2025 | Hahn Mark W | CFO | Sell | 32.5 | -400,000 | -3.06% | ✓ | $3.7M |
| May 27, 2025 | May 29, 2025 | ZACCARDELLI DAVID | CEO | Sell | 36.3 | -400,000 | -2.86% | ✓ | $3.7M |
| May 20, 2025 | May 22, 2025 | Sinha Vikas | Director | Sell | 5.0 | -160,000 | -68.25% | ✓ | $1.5M |
| Apr 29, 2025 | May 22, 2025 | Sinha Vikas | Director | Sell | 5.0 | -160,000 | -51.80% | ✓ | $1.4M |
| May 15, 2025 | May 16, 2025 | Fisher Andrew | General Counsel | Sell | 17.5 | -80,000 | -18.18% | ✓ | $685.6K |
| May 14, 2025 | May 16, 2025 | ACKERMANN CHRISTINA | Director | Sell | 7.5 | -40,000 | -48.85% | ✓ | $337.6K |
| May 6, 2025 | May 8, 2025 | Rickard Kathleen A. | Chief Medical Officer | Sell | 32.5 | -114,984 | -4.32% | ✓ | $1M |
| May 1, 2025 | May 5, 2025 | Rickard Kathleen A. | Chief Medical Officer | Sell | 45.0 | -49,200 | -0.92% | ✓ | $440.3K |
| May 1, 2025 | May 5, 2025 | Hahn Mark W | CFO | Sell | 38.8 | -587,008 | -1.45% | ✓ | $5.3M |
| May 1, 2025 | May 5, 2025 | EBSWORTH DAVID R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 1, 2025 | May 5, 2025 | ZACCARDELLI DAVID | CEO | Sell | 38.8 | -587,008 | -1.36% | ✓ | $5.3M |
| Mar 19, 2025 | May 1, 2025 | Fisher Andrew | General Counsel | Sell | 22.5 | -26,071 | -3.80% | ✗ | $234.1K |
| Apr 29, 2025 | May 1, 2025 | ZACCARDELLI DAVID | CEO | Sell | 45.0 | -90,360 | -0.62% | ✓ | $811.4K |
| Apr 29, 2025 | May 1, 2025 | Rickard Kathleen A. | Chief Medical Officer | Sell | 42.5 | -34,384 | -1.28% | ✓ | $308.8K |
| Apr 29, 2025 | May 1, 2025 | Hahn Mark W | CFO | Sell | 45.0 | -90,360 | -0.67% | ✓ | $811.4K |
| Apr 29, 2025 | May 1, 2025 | Sinha Vikas | Director | Sell | 25.0 | -20,000 | -11.84% | ✓ | $178.4K |
| Apr 25, 2025 | Apr 29, 2025 | EBSWORTH DAVID R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 25, 2025 | Apr 29, 2025 | Ullman Anders | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 25, 2025 | Apr 29, 2025 | Sinha Vikas | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 25, 2025 | Apr 29, 2025 | SHAH MAHENDRA | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 25, 2025 | Apr 29, 2025 | Edwards Martin | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 25, 2025 | Apr 29, 2025 | Deschamps Lisa | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 25, 2025 | Apr 29, 2025 | Cunningham Kenneth | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 25, 2025 | Apr 29, 2025 | Austwick Michael | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 25, 2025 | Apr 29, 2025 | Brady James Aloysius | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 25, 2025 | Apr 29, 2025 | ACKERMANN CHRISTINA | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 12, 2025 | Mar 13, 2025 | Rickard Kathleen A. | Chief Medical Officer | Sell | 38.8 | -79,264 | -2.95% | ✓ | $661.9K |
| Feb 26, 2025 | Feb 28, 2025 | EBSWORTH DAVID R | Director | Neutral | 27.5 | -64,000 | -4.57% | ✗ | - |
| Feb 1, 2025 | Feb 4, 2025 | ZACCARDELLI DAVID | CEO | Sell | 70.0 | +33,272 | 0.23% | ✗ | $1.2M |
| Feb 1, 2025 | Feb 4, 2025 | Hahn Mark W | CFO | Sell | 70.0 | +33,112 | 0.25% | ✗ | $1.2M |
| Feb 1, 2025 | Feb 4, 2025 | Rickard Kathleen A. | Chief Medical Officer | Sell | 72.5 | +16,760 | 0.63% | ✗ | $238.1K |
| Dec 4, 2024 | Dec 6, 2024 | ZACCARDELLI DAVID | CEO | Sell | 27.5 | -870,672 | -5.78% | ✓ | $4.4M |
| Dec 4, 2024 | Dec 6, 2024 | Hahn Mark W | CFO | Sell | 27.5 | -881,960 | -6.22% | ✓ | $4.4M |
| Nov 27, 2024 | Dec 2, 2024 | Hahn Mark W | CFO | Sell | 45.0 | -113,240 | -0.79% | ✓ | $566.8K |
| Nov 27, 2024 | Dec 2, 2024 | ZACCARDELLI DAVID | CEO | Sell | 45.0 | -125,328 | -0.82% | ✓ | $627.2K |
| Nov 25, 2024 | Nov 26, 2024 | Hahn Mark W | CFO | Sell | 57.5 | -2,400 | -0.02% | ✓ | $12K |
| Nov 25, 2024 | Nov 26, 2024 | ZACCARDELLI DAVID | CEO | Sell | 58.8 | -1,600 | -0.01% | ✓ | $8K |
| Nov 25, 2024 | Nov 26, 2024 | Rickard Kathleen A. | Chief Medical Officer | Sell | 23.8 | -240,000 | -8.24% | ✓ | $1.2M |
| Nov 18, 2024 | Nov 18, 2024 | EBSWORTH DAVID R | Director | Buy | 82.5 | +20,000 | 2.17% | ✗ | $88.8K |
| Nov 11, 2024 | Nov 13, 2024 | ZACCARDELLI DAVID | CEO | Sell | 57.5 | -2,400 | -0.02% | ✓ | $12K |
| Nov 11, 2024 | Nov 13, 2024 | Hahn Mark W | CFO | Sell | 57.5 | -2,400 | -0.02% | ✓ | $12K |
| Nov 6, 2024 | Nov 7, 2024 | EBSWORTH DAVID R | Director | Buy | 87.5 | +39,360 | 4.47% | ✗ | $188.9K |
| Nov 6, 2024 | Nov 7, 2024 | ACKERMANN CHRISTINA | Director | Buy | 95.0 | +41,880 | 100.00% | ✗ | $198.4K |
| Nov 1, 2024 | Nov 5, 2024 | ZACCARDELLI DAVID | CEO | Sell | 45.0 | -141,032 | -0.92% | ✓ | $618.7K |
| Nov 1, 2024 | Nov 5, 2024 | Hahn Mark W | CFO | Sell | 45.0 | -129,672 | -0.90% | ✓ | $568.4K |
| Oct 30, 2024 | Nov 1, 2024 | ZACCARDELLI DAVID | CEO | Sell | 95.0 | +754,048 | 5.17% | ✗ | $1M |
| Oct 30, 2024 | Nov 1, 2024 | Rickard Kathleen A. | Chief Medical Officer | Sell | 97.5 | +284,064 | 10.81% | ✗ | $279.6K |
| Oct 30, 2024 | Nov 1, 2024 | Hahn Mark W | CFO | Sell | 95.0 | +754,048 | 5.52% | ✗ | $1M |
| Oct 30, 2024 | Nov 1, 2024 | Fisher Andrew | General Counsel | Neutral | 90.0 | +300,000 | 100.00% | ✗ | - |
| Oct 24, 2024 | Oct 25, 2024 | Hahn Mark W | CFO | Sell | 42.5 | -144,560 | -1.05% | ✓ | $632.8K |
| Oct 23, 2024 | Oct 25, 2024 | ZACCARDELLI DAVID | CEO | Sell | 45.0 | -144,816 | -0.98% | ✓ | $633.9K |
| Oct 18, 2024 | Oct 22, 2024 | ZACCARDELLI DAVID | CEO | Sell | 32.5 | -514,152 | -3.37% | ✓ | $2.3M |
| Oct 18, 2024 | Oct 22, 2024 | Hahn Mark W | CFO | Sell | 32.5 | -525,768 | -3.67% | ✓ | $2.3M |
| Sep 11, 2024 | Sep 13, 2024 | ZACCARDELLI DAVID | CEO | Sell | 32.5 | -600,000 | -3.79% | ✓ | $2.3M |
| Sep 11, 2024 | Sep 13, 2024 | Hahn Mark W | CFO | Sell | 32.5 | -600,000 | -4.02% | ✓ | $2.3M |
| Aug 12, 2024 | Aug 14, 2024 | ZACCARDELLI DAVID | CEO | Sell | 36.3 | -400,000 | -2.46% | ✓ | $1.3M |
| Aug 12, 2024 | Aug 14, 2024 | Hahn Mark W | CFO | Sell | 36.3 | -400,000 | -2.61% | ✓ | $1.3M |
| Aug 12, 2024 | Aug 14, 2024 | EBSWORTH DAVID R | Director | Buy | 87.5 | +36,000 | 4.26% | ✗ | $103.3K |
| Aug 7, 2024 | Aug 9, 2024 | ZACCARDELLI DAVID | CEO | Sell | 90.0 | +485,200 | 3.08% | ✗ | $824.8K |
| Aug 7, 2024 | Aug 9, 2024 | Rickard Kathleen A. | Chief Medical Officer | Sell | 87.5 | +112,096 | 4.46% | ✗ | $230.3K |
| Aug 7, 2024 | Aug 9, 2024 | Hahn Mark W | CFO | Sell | 90.0 | +485,200 | 3.27% | ✗ | $824.8K |